Connable Office Inc’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Sell
5,607
-99
-2% -$53.7K 0.27% 53
2025
Q4
$3.31M Sell
5,706
-17
-0.3% -$9.61K 0.3% 42
2025
Q3
$2.78M Buy
5,723
+84
+1% +$39.1K 0.26% 51
2025
Q2
$2.29M Buy
5,639
+94
+2% +$39.3K 0.23% 59
2025
Q1
$2.76M Sell
5,545
-254
-4% -$138K 0.29% 52
2024
Q4
$3.02M Sell
5,799
-118
-2% -$64.9K 0.31% 50
2024
Q3
$3.66M Buy
5,917
+20
+0.3% +$11.8K 0.37% 39
2024
Q2
$3.26M Sell
5,897
-139
-2% -$79.6K 0.35% 44
2024
Q1
$3.51M Sell
6,036
-1,015
-14% -$570K 0.4% 42
2023
Q4
$3.74M Sell
7,051
-51
-0.7% -$24.7K 0.45% 39
2023
Q3
$3.59M Sell
7,102
-1,222
-15% -$651K 0.49% 36
2023
Q2
$4.34M Sell
8,324
-107
-1% -$57.7K 0.6% 32
2023
Q1
$4.86M Sell
8,431
-166
-2% -$93.6K 0.71% 21
2022
Q4
$4.73M Buy
8,597
+92
+1% +$48.7K 0.68% 24
2022
Q3
$4.31M Sell
8,505
-205
-2% -$115K 0.7% 23
2022
Q2
$4.73M Sell
8,710
-121
-1% -$66.6K 0.72% 18
2022
Q1
$5.22M Buy
8,831
+155
+2% +$89K 0.7% 19
2021
Q4
$5.79M Sell
8,676
-110
-1% -$68.7K 0.74% 21
2021
Q3
$5.02M Sell
8,786
-447
-5% -$245K 0.73% 22
2021
Q2
$4.66M Sell
9,233
-140
-1% -$66.1K 0.65% 27
2021
Q1
$4.28M Sell
9,373
-1,334
-12% -$637K 0.62% 27
2020
Q4
$4.99M Buy
10,707
+316
+3% +$148K 0.77% 19
2020
Q3
$4.59M Sell
10,391
-1,054
-9% -$435K 0.86% 17
2020
Q2
$4.15M Sell
11,445
-2,584
-18% -$866K 0.82% 16
2020
Q1
$3.98M Sell
14,029
-290
-2% -$91.4K 0.95% 15
2019
Q4
$4.65M Sell
14,319
-238
-2% -$72.2K 0.8% 19
2019
Q3
$4.24M Buy
14,557
+131
+0.9% +$37.5K 0.76% 19
2019
Q2
$4.24M Sell
14,426
-449
-3% -$124K 0.78% 19
2019
Q1
$4.07M Sell
14,875
-1,191
-7% -$296K 0.79% 21
2018
Q4
$3.6M Sell
16,066
-1,571
-9% -$369K 0.79% 20
2018
Q3
$4.3M Sell
17,637
-270
-2% -$62.1K 0.83% 21
2018
Q2
$3.71M Hold
17,907
0.75% 21
2018
Q1
$3.7M Sell
17,907
-823
-4% -$173K 0.73% 23
2017
Q4
$3.56M Sell
18,730
-1,147
-6% -$220K 0.69% 24
2017
Q3
$3.76M Sell
19,877
-1,331
-6% -$241K 0.77% 20
2017
Q2
$3.7M Sell
21,208
-761
-3% -$128K 0.81% 21
2017
Q1
$3.37M Buy
21,969
+2,397
+12% +$366K 0.76% 29
2016
Q4
$2.76M Sell
19,572
-622
-3% -$91.7K 0.63% 40
2016
Q3
$3.21M Sell
20,194
-160
-0.8% -$24.7K 0.77% 26
2016
Q2
$3.01M Sell
20,354
-364
-2% -$53.7K 0.84% 26
2016
Q1
$2.93M Sell
20,718
-58
-0.3% -$7.77K 0.81% 27
2015
Q4
$2.95M Sell
20,776
-783
-4% -$104K 0.85% 31
2015
Q3
$2.64M Sell
21,559
-1,853
-8% -$241K 0.78% 30
2015
Q2
$3.04M Hold
23,412
0.81% 32
2015
Q1
$3.15M Buy
23,412
+78
+0.3% +$10.1K 0.8% 34
2014
Q4
$2.92M Hold
23,334
0.79% 38
2014
Q3
$2.84M Sell
23,334
-84
-0.4% -$10.2K 0.75% 38
2014
Q2
$2.76M Sell
23,418
-127
-0.5% -$14.9K 0.71% 41
2014
Q1
$2.83M Sell
23,545
-10,251
-30% -$1.22M 0.77% 39
2013
Q4
$3.76M Sell
33,796
-87
-0.3% -$8.65K 1.02% 23
2013
Q3
$3.12M Sell
33,883
-69
-0.2% -$6.24K 0.88% 26
2013
Q2
$2.87M Buy
+33,952
New +$2.83M 0.82% 30

Other funds holding TMO

Connable Office Inc's TMO Position: Q1 2026 in Review

Connable Office Inc reduced its Thermo Fisher Scientific (TMO) stake by 1.7% in Q1 2026, selling an estimated $53.7K and leaving 5,607 shares worth $2.76M. The position accounts for 0.27% of the portfolio, ranked #53.

Connable Office Inc first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.79M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Connable Office Inc held 5,607 shares of Thermo Fisher Scientific worth $2.76M as of Q1 2026.
  • Connable Office Inc sold 99 Thermo Fisher Scientific shares in Q1 2026, an estimated $53.7K.
  • Thermo Fisher Scientific made up 0.27% of Connable Office Inc's portfolio in Q1 2026, its #53 holding.
  • Connable Office Inc first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Connable Office Inc's Thermo Fisher Scientific position peaked at $5.79M in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Connable Office Inc's 13F filing for Q1 2026, filed 29 Apr 2026.